| Completed | 1 | 9 | US | IL-2, Proleukin, Rapamycin, Rapamune, Sirolimus | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN) | Diabetes Mellitus, Type 1 | 09/11 | 09/13 | | |
NCT01313923: Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus |
|
|
| Terminated | 1 | 3 | US | Sirolimus (formerly known as Rapamycin), Sirolimus, Rapamycin | University of California, Irvine | Pemphigus | 10/14 | 10/14 | | |
